152 related articles for article (PubMed ID: 35527512)
1. Renal Transporter-Mediated Drug-Biomarker Interactions of the Endogenous Substrates Creatinine and N
Türk D; Müller F; Fromm MF; Selzer D; Dallmann R; Lehr T
Clin Pharmacol Ther; 2022 Sep; 112(3):687-698. PubMed ID: 35527512
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic in vitro studies confirm that inhibition of the renal apical efflux transporter multidrug and toxin extrusion (MATE) 1, and not altered absorption, underlies the increased metformin exposure observed in clinical interactions with cimetidine, trimethoprim or pyrimethamine.
Elsby R; Chidlaw S; Outteridge S; Pickering S; Radcliffe A; Sullivan R; Jones H; Butler P
Pharmacol Res Perspect; 2017 Oct; 5(5):. PubMed ID: 28971610
[TBL] [Abstract][Full Text] [Related]
3. N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.
Müller F; Pontones CA; Renner B; Mieth M; Hoier E; Auge D; Maas R; Zolk O; Fromm MF
Eur J Clin Pharmacol; 2015 Jan; 71(1):85-94. PubMed ID: 25552403
[TBL] [Abstract][Full Text] [Related]
4. Identification of Appropriate Endogenous Biomarker for Risk Assessment of Multidrug and Toxin Extrusion Protein-Mediated Drug-Drug Interactions in Healthy Volunteers.
Miyake T; Kimoto E; Luo L; Mathialagan S; Horlbogen LM; Ramanathan R; Wood LS; Johnson JG; Le VH; Vourvahis M; Rodrigues AD; Muto C; Furihata K; Sugiyama Y; Kusuhara H
Clin Pharmacol Ther; 2021 Feb; 109(2):507-516. PubMed ID: 32866300
[TBL] [Abstract][Full Text] [Related]
5. N
Müller F; Hohl K; Keller S; Schmidt-Gerets S; Deutsch B; Schuler-Metz A; Fromm MF; Stopfer P; Gessner A
Clin Pharmacol Ther; 2023 May; 113(5):1070-1079. PubMed ID: 36636898
[TBL] [Abstract][Full Text] [Related]
6. N-methylnicotinamide is an endogenous probe for evaluation of drug-drug interactions involving multidrug and toxin extrusions (MATE1 and MATE2-K).
Ito S; Kusuhara H; Kumagai Y; Moriyama Y; Inoue K; Kondo T; Nakayama H; Horita S; Tanabe K; Yuasa H; Sugiyama Y
Clin Pharmacol Ther; 2012 Nov; 92(5):635-41. PubMed ID: 23047651
[TBL] [Abstract][Full Text] [Related]
7. Elucidation of
Miyake T; Mizuno T; Takehara I; Mochizuki T; Kimura M; Matsuki S; Irie S; Watanabe N; Kato Y; Ieiri I; Maeda K; Ando O; Kusuhara H
Drug Metab Dispos; 2019 Nov; 47(11):1270-1280. PubMed ID: 31511257
[TBL] [Abstract][Full Text] [Related]
8. Effect of Cimetidine on Metformin Pharmacokinetics and Endogenous Metabolite Levels in Rats.
Ailabouni AS; Mettu VS; Thakur A; Singh DK; Prasad B
Drug Metab Dispos; 2024 Jan; 52(2):86-94. PubMed ID: 38049999
[TBL] [Abstract][Full Text] [Related]
9. A Multiplexed HILIC-MS/HRMS Assay for the Assessment of Transporter Inhibition Biomarkers in Phase I Clinical Trials: Isobutyryl-Carnitine as an Organic Cation Transporter (OCT1) Biomarker.
Luo L; Ramanathan R; Horlbogen L; Mathialagan S; Costales C; Vourvahis M; Holliman CL; Rodrigues AD
Anal Chem; 2020 Jul; 92(14):9745-9754. PubMed ID: 32551505
[TBL] [Abstract][Full Text] [Related]
10. Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactions.
Burt HJ; Neuhoff S; Almond L; Gaohua L; Harwood MD; Jamei M; Rostami-Hodjegan A; Tucker GT; Rowland-Yeo K
Eur J Pharm Sci; 2016 Jun; 88():70-82. PubMed ID: 27019345
[TBL] [Abstract][Full Text] [Related]
11. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
Müller F; König J; Hoier E; Mandery K; Fromm MF
Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
[TBL] [Abstract][Full Text] [Related]
12. A Physiologically-Based Pharmacokinetic Model of Trimethoprim for MATE1, OCT1, OCT2, and CYP2C8 Drug-Drug-Gene Interaction Predictions.
Türk D; Hanke N; Lehr T
Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33182761
[TBL] [Abstract][Full Text] [Related]
13. Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug-drug interactions via CYP3A metabolism and transporters.
Barth A; Perry CR; Shabbir S; Zamek-Gliszczynski MJ; Thomas S; Dumont EF; Brimhall DB; Nguyen D; Srinivasan M; Swift B
Clin Transl Sci; 2023 Apr; 16(4):647-661. PubMed ID: 36642822
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy Increases the Renal Secretion of N
Bergagnini-Kolev MC; Hebert MF; Easterling TR; Lin YS
Drug Metab Dispos; 2017 Mar; 45(3):325-329. PubMed ID: 28069720
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Effect of Abrocitinib on Drug Transporters by Integrated Use of Probe Drugs and Endogenous Biomarkers.
Vourvahis M; Byon W; Chang C; Le V; Diehl A; Graham D; Tripathy S; Raha N; Luo L; Mathialagan S; Dowty M; Rodrigues AD; Malhotra B
Clin Pharmacol Ther; 2022 Sep; 112(3):665-675. PubMed ID: 35344588
[TBL] [Abstract][Full Text] [Related]
16. Physiologically-Based Pharmacokinetic Modeling Analysis for Quantitative Prediction of Renal Transporter-Mediated Interactions Between Metformin and Cimetidine.
Nishiyama K; Toshimoto K; Lee W; Ishiguro N; Bister B; Sugiyama Y
CPT Pharmacometrics Syst Pharmacol; 2019 Jun; 8(6):396-406. PubMed ID: 30821133
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Consideration of Clinical Increases in Serum Creatinine Caused by Renal Transporter Inhibition.
Nakada T; Kudo T; Ito K
Drug Metab Dispos; 2023 Sep; 51(9):1114-1126. PubMed ID: 36859345
[TBL] [Abstract][Full Text] [Related]
18. Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions.
Hanke N; Gómez-Mantilla JD; Ishiguro N; Stopfer P; Nock V
Pharm Res; 2021 Oct; 38(10):1645-1661. PubMed ID: 34664206
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of elevation of serum creatinine via renal transporter inhibition by trimethoprim in healthy subjects using physiologically-based pharmacokinetic model.
Nakada T; Kudo T; Kume T; Kusuhara H; Ito K
Drug Metab Pharmacokinet; 2018 Feb; 33(1):103-110. PubMed ID: 29361388
[TBL] [Abstract][Full Text] [Related]
20. A Whole-Body Physiologically Based Pharmacokinetic Model Characterizing Interplay of OCTs and MATEs in Intestine, Liver and Kidney to Predict Drug-Drug Interactions of Metformin with Perpetrators.
Yang Y; Zhang Z; Li P; Kong W; Liu X; Liu L
Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34064886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
